For the quarter ending 2025-09-30, XTNT made $33,255,000 in revenue. $1,308,000 in net income. Net profit margin of 3.93%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenue | 33,255,000 | 35,411,000 | 32,904,000 | 28,942,500 |
| Cost of sales | 11,263,000 | 11,127,000 | 12,661,000 | 13,030,000 |
| Gross profit | 21,992,000 | 24,284,000 | 20,243,000 | 16,663,500 |
| General and administrative | 7,071,000 | 7,478,000 | 7,533,000 | 6,742,500 |
| Sales and marketing | 11,746,000 | 11,616,000 | 11,204,000 | 12,072,500 |
| Research and development | 634,000 | 566,000 | 443,000 | 524,000 |
| Total operating expenses | 19,451,000 | 19,660,000 | 19,180,000 | 19,339,000 |
| Income (loss) from operations | 2,541,000 | 4,624,000 | 1,063,000 | -2,675,500 |
| Interest expense | 904,000 | 1,004,000 | 1,045,000 | 984,500 |
| Unrealized foreign currency translation (loss) gain | -56,000 | 178,000 | 24,000 | -70,000 |
| Other expense | -16,000 | 7,000 | -9,000 | -6,666.667 |
| Total other expense | -976,000 | -819,000 | -1,030,000 | -1,062,000 |
| Net income (loss) from operations before provision for income taxes | 1,565,000 | 3,805,000 | 33,000 | -3,737,500 |
| Provision for income taxes current and deferred | 257,000 | 255,000 | -25,000 | 44,500 |
| Net income (loss) | 1,308,000 | 3,550,000 | 58,000 | -3,782,000 |
| Basic | 0.01 | 0.03 | 0 | -0.025 |
| Basic | 139,712,969 | 139,310,589 | 139,068,831 | -65,852,434 |
| Dilutive | 0.01 | 0.02 | 0 | -0.025 |
| Dilutive | 150,377,234 | 148,574,242 | 143,335,114 | -65,852,434 |
Xtant Medical Holdings, Inc. (XTNT)
Xtant Medical Holdings, Inc. (XTNT)